HUE042711T2 - Neosaxitoxin kombinációs készítmények meghosszabbított helyi érzéstelenítésre - Google Patents
Neosaxitoxin kombinációs készítmények meghosszabbított helyi érzéstelenítésreInfo
- Publication number
- HUE042711T2 HUE042711T2 HUE14719486A HUE14719486A HUE042711T2 HU E042711 T2 HUE042711 T2 HU E042711T2 HU E14719486 A HUE14719486 A HU E14719486A HU E14719486 A HUE14719486 A HU E14719486A HU E042711 T2 HUE042711 T2 HU E042711T2
- Authority
- HU
- Hungary
- Prior art keywords
- local anesthesia
- combination formulations
- prolonged local
- neosaxitoxin
- neosaxitoxin combination
- Prior art date
Links
- PPEKGEBBBBNZKS-UHFFFAOYSA-N Neosaxitoxin Natural products N=C1N(O)C(COC(=O)N)C2N=C(N)NC22C(O)(O)CCN21 PPEKGEBBBBNZKS-UHFFFAOYSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000002690 local anesthesia Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- PPEKGEBBBBNZKS-HGRQIUPRSA-N neosaxitoxin Chemical compound N=C1N(O)[C@@H](COC(=O)N)[C@@H]2NC(=N)N[C@@]22C(O)(O)CCN21 PPEKGEBBBBNZKS-HGRQIUPRSA-N 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789054P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE042711T2 true HUE042711T2 (hu) | 2019-07-29 |
Family
ID=50549480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14719486A HUE042711T2 (hu) | 2013-03-15 | 2014-03-17 | Neosaxitoxin kombinációs készítmények meghosszabbított helyi érzéstelenítésre |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US10314833B2 (hu) |
| EP (2) | EP3492075B1 (hu) |
| JP (1) | JP6313420B2 (hu) |
| KR (4) | KR20220132666A (hu) |
| CN (1) | CN105142625B (hu) |
| AU (2) | AU2014232881B2 (hu) |
| CA (2) | CA3018668C (hu) |
| CL (1) | CL2015002534A1 (hu) |
| CY (1) | CY1121606T1 (hu) |
| DK (1) | DK2968225T3 (hu) |
| ES (1) | ES2727292T3 (hu) |
| HK (1) | HK1218384A1 (hu) |
| HR (1) | HRP20190419T1 (hu) |
| HU (1) | HUE042711T2 (hu) |
| IL (1) | IL241346B (hu) |
| LT (1) | LT2968225T (hu) |
| MX (1) | MX2015012879A (hu) |
| NZ (1) | NZ710890A (hu) |
| PE (1) | PE20160011A1 (hu) |
| PL (2) | PL3492075T3 (hu) |
| PT (1) | PT2968225T (hu) |
| RS (1) | RS58750B1 (hu) |
| RU (2) | RU2015143665A (hu) |
| SI (1) | SI2968225T1 (hu) |
| TR (1) | TR201903411T4 (hu) |
| WO (1) | WO2014145580A1 (hu) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ710890A (en) * | 2013-03-15 | 2016-11-25 | Childrens Medical Ct Corp | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US20170368176A1 (en) | 2014-12-15 | 2017-12-28 | The Children's Medical Center Corporation | Non-toxic topical anesthetic ophthalmic compositions |
| EP3359134A1 (en) | 2015-10-08 | 2018-08-15 | The Children's Medical Center Corporation | Compositions and methods for on-demand high-efficiency triggerable anesthesia |
| US10117847B2 (en) | 2015-12-04 | 2018-11-06 | Ventis Pharma | Extended duration local anesthetic formulation |
| US10791651B2 (en) | 2016-05-31 | 2020-09-29 | Carbice Corporation | Carbon nanotube-based thermal interface materials and methods of making and using thereof |
| JP2021505550A (ja) * | 2017-12-01 | 2021-02-18 | ザ チルドレンズ メディカル センター コーポレーション | 長時間の局所麻酔のための麻酔薬−ポリマー共有結合性コンジュゲート |
| RU2701571C1 (ru) * | 2019-02-13 | 2019-09-30 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Казанский Государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики болевого синдрома после вмешательств на коленном суставе |
| WO2021141956A1 (en) * | 2020-01-06 | 2021-07-15 | Pacira Pharmaceuticals, Inc, | Treatment of pain associated with cesarean section surgery with sustained-release liposomal anesthetic compositions |
| US20230130180A1 (en) | 2020-01-10 | 2023-04-27 | Pacira Pharmaceuticals, Inc. | Treatment of pain by administration of sustained-release liposomal anesthetic compositions |
| WO2021141963A1 (en) | 2020-01-10 | 2021-07-15 | Pacira Pharmaceuticals, Inc. | Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions |
| EP4274573A1 (en) | 2021-01-11 | 2023-11-15 | Pacira Pharmaceuticals, Inc. | Treatment of hip pain with sustained-release liposomal anesthetic compositions |
| CN117320696A (zh) | 2021-03-19 | 2023-12-29 | 帕西拉制药股份有限公司 | 通过给予缓释脂质体麻醉组合物治疗儿科患者的疼痛 |
| US11918565B1 (en) | 2022-11-03 | 2024-03-05 | Pacira Pharmaceuticals, Inc. | Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3004894A (en) | 1959-04-07 | 1961-10-17 | Upjohn Co | Therapeutic composition comprising tetracycline and a dioxolane |
| US3328259A (en) | 1964-01-08 | 1967-06-27 | Parachem Corp | Dressing for a wound containing a hemostatic agent and method of treating a wound |
| US3374144A (en) | 1965-10-07 | 1968-03-19 | Miles Lab | Ophthalmic composition |
| SE391127B (sv) | 1971-01-26 | 1977-02-07 | Astra Pharma Prod | Forfarande for framstellning av en lokalanetetiskt verksam injektionslosning med forlengd varaktighet av verkan |
| US3966934A (en) | 1971-12-08 | 1976-06-29 | Astra Pharmaceutical Products, Inc. | Synergistic local anesthetic compositions |
| US3957996A (en) | 1971-12-08 | 1976-05-18 | Astra Pharmaceutical Products, Inc. | Pharmaceutical local anesthetic compositions |
| US4029793A (en) | 1973-06-12 | 1977-06-14 | Astra Pharmaceutical Products, Inc. | Synergistic local anesthetic compositions |
| US4022899A (en) | 1973-06-12 | 1977-05-10 | Astra Pharmaceutical Products, Inc. | Synergistic local anesthetic compositions |
| US4001413A (en) | 1973-06-12 | 1977-01-04 | Astra Pharmaceutical Products, Inc. | Pharmaceutical local anesthetic composition employing saxitoxin |
| US4029794A (en) | 1973-06-12 | 1977-06-14 | Astra Pharmaceutical Products, Inc. | Pharmaceutical local anesthetic composition |
| CA1165240A (en) | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| US4313958A (en) | 1980-10-24 | 1982-02-02 | The Procter & Gamble Company | Method of producing analgesia |
| US4460602A (en) | 1981-06-30 | 1984-07-17 | The Procter & Gamble Company | Urea derivatives |
| US4401663A (en) | 1981-06-30 | 1983-08-30 | The Procter & Gamble Company | Novel sulfonamide derivatives |
| US4443473A (en) | 1981-06-30 | 1984-04-17 | The Procter & Gamble Company | Carbamate derivatives |
| US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
| US4544669A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
| US4564633A (en) | 1983-07-14 | 1986-01-14 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
| US4544668A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
| US4493848A (en) | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
| US4605670A (en) | 1984-02-01 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering metoclopramide |
| CA1274508A (en) | 1984-05-31 | 1990-09-25 | Imre Szilagyi | Primycin components and process for the separation of the antibiotic complex |
| US4654323A (en) | 1984-11-13 | 1987-03-31 | Bar Ilan University | Method and composition for the therapeutic and prophylactic treatment of trauma to the skin |
| US5013759A (en) | 1985-06-10 | 1991-05-07 | The Procter & Gamble Company | Compounds and compositions having anti-inflammatory and analgesic activity |
| US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| US5006342A (en) | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
| US5045565A (en) | 1987-03-09 | 1991-09-03 | The Procter & Gamble Company | Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain |
| US5099030A (en) | 1987-03-09 | 1992-03-24 | The Procter & Gamble Company | Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain |
| US4820720A (en) | 1987-08-24 | 1989-04-11 | Alza Corporation | Transdermal drug composition with dual permeation enhancers |
| US5871472A (en) | 1987-11-17 | 1999-02-16 | Brown University Research Foundation | Planting devices for the focal release of neuroinhibitory compounds |
| US5008289A (en) | 1988-12-02 | 1991-04-16 | Galenpharma, Inc. | Composition for treating nasal disorders and headaches |
| US4997853A (en) | 1988-12-02 | 1991-03-05 | Galenpharma, Inc. | Method and compositions utilizing capsaicin as an external analgesic |
| US5134166A (en) | 1988-12-02 | 1992-07-28 | Genderm Corporation | Method for treating nasal disorders and headaches |
| US4973468A (en) | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
| MX9207344A (es) | 1991-12-16 | 1993-07-01 | Alza Corp | Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla. |
| WO1994005265A1 (en) | 1992-09-10 | 1994-03-17 | Children's Medical Center Corporation | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| US5700485A (en) | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| WO1995024903A1 (fr) | 1994-03-17 | 1995-09-21 | Nanning Maple Leaf Pharmaceutical Co., Ltd. | Application de composes de quinazoline amino-hydrogenes et de leurs derives au sevrage des toxicomanes |
| CA2195119C (en) | 1995-06-09 | 2001-09-11 | Mark Chasin | Formulations and methods for providing prolonged local anesthesia |
| US5858397A (en) | 1995-10-11 | 1999-01-12 | University Of British Columbia | Liposomal formulations of mitoxantrone |
| AU6883798A (en) | 1997-04-02 | 1998-10-22 | Regents Of The University Of California, The | Method of anesthesia |
| US6326020B1 (en) | 1997-05-16 | 2001-12-04 | Children's Medical Center Corporation | Local anesthetic formulations |
| US7016870B1 (en) | 1997-12-02 | 2006-03-21 | Financial Engines | Identifying a recommended portfolio of financial products for an investor based upon financial products that are available to the investor |
| WO2001041550A2 (en) | 1999-10-22 | 2001-06-14 | Transdermatech, Inc. | Topical anesthetic formulation |
| US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
| US6455066B1 (en) | 2000-03-10 | 2002-09-24 | Epicept Corporation | Intradermal-penetration agents for topical local anesthetic administration |
| CN1284536C (zh) | 2000-09-18 | 2006-11-15 | 威克斯医药有限公司 | 河豚毒素或蛤蚌毒素及其类似物在制备用于全身镇痛的镇痛药中的应用 |
| CN1236773C (zh) | 2000-11-22 | 2006-01-18 | 南宁枫叶药业有限公司 | 用于镇痛、麻醉或治疗药物依赖性的制剂 |
| US20030152637A1 (en) * | 2001-01-25 | 2003-08-14 | Mark Chasin | Local anesthetic, and method of use |
| CN1382443A (zh) | 2001-04-25 | 2002-12-04 | 威克斯医疗仪器有限公司 | 钠离子通道阻断剂在制备用于局部神经麻醉或镇痛的药物中的应用 |
| ES2401570T3 (es) | 2001-11-15 | 2013-04-22 | Phytotox Limited | Composiciones farmacéuticas que contienen 3,4-propinoperhidropurinas y usos de las mismas para bloquear la transmisión neuronal |
| WO2004050034A2 (en) | 2002-12-02 | 2004-06-17 | Massachusetts Institute Of Technology | Prolonged suppression of electrical activity in excitable tissues |
| US20040172354A1 (en) | 2003-02-13 | 2004-09-02 | Charnley James Allen | Calculator for illustrating investment performance for irregular time periods |
| WO2005079157A2 (en) | 2004-02-19 | 2005-09-01 | Dmitry Gorbatovsky | Portfolio optimization |
| US20050214325A1 (en) | 2004-03-26 | 2005-09-29 | Vvii Newco 2003, Inc. | Compositions and methods to increase the effect of a neurotoxin treatment |
| AU2005244096B2 (en) | 2004-05-07 | 2011-03-17 | Algenis Spa | Transdermal administration of phycotoxins |
| CN100367966C (zh) | 2004-09-28 | 2008-02-13 | 黄致强 | 河鲀毒素油相制剂的制备方法 |
| WO2006091719A2 (en) | 2005-02-23 | 2006-08-31 | Sontra Medical Corporation | Compositions and methods enhancing transdermal delivery of drugs and biologics |
| EP2101819B1 (en) | 2006-11-20 | 2013-01-09 | President and Fellows of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
| US8609733B2 (en) | 2008-05-19 | 2013-12-17 | Massachusetts Institute Of Technology | Sensory-specific local anesthesia and prolonged duration local anesthesia |
| US8658699B2 (en) | 2008-05-19 | 2014-02-25 | Massachusetts Institute Of Technology | Chemical permeation enhancers enhance nerve blockade by toxins |
| US20110250266A1 (en) | 2008-10-07 | 2011-10-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Liposomal systems comprising sphingomyelin |
| CL2009000722A1 (es) | 2009-03-24 | 2009-06-19 | Proteus Sa | Metodo de obtención y producción masiva de una especie de cianobacteria aislada productora de ficotoxinas paralizantes, utilizando un medio de cultivo mla suplementado con arginina, metionina y ácido alantoico. |
| CL2009000723A1 (es) | 2009-03-24 | 2009-06-19 | Proteus Sa | Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias. |
| WO2010117996A1 (en) | 2009-04-08 | 2010-10-14 | Children's Medical Center Corporation | Prolonged duration local anesthesia with minimal toxicity |
| EP2459565B1 (en) | 2009-05-07 | 2018-05-02 | The Board of Trustees of The Leland Stanford Junior University | Saxitoxin derivatives, methods and compositions for studying, imaging, and treating pain |
| EP2533785B1 (en) * | 2010-02-10 | 2014-04-23 | Phytotox Limited | Treatment of loss of sense of touch with saxitoxin derivatives |
| NZ710890A (en) * | 2013-03-15 | 2016-11-25 | Childrens Medical Ct Corp | Neosaxitoxin combination formulations for prolonged local anesthesia |
-
2014
- 2014-03-17 NZ NZ710890A patent/NZ710890A/en unknown
- 2014-03-17 US US14/216,252 patent/US10314833B2/en active Active
- 2014-03-17 SI SI201431117T patent/SI2968225T1/sl unknown
- 2014-03-17 KR KR1020227032390A patent/KR20220132666A/ko not_active Application Discontinuation
- 2014-03-17 HU HUE14719486A patent/HUE042711T2/hu unknown
- 2014-03-17 PE PE2015002008A patent/PE20160011A1/es unknown
- 2014-03-17 PL PL18215029.2T patent/PL3492075T3/pl unknown
- 2014-03-17 TR TR2019/03411T patent/TR201903411T4/tr unknown
- 2014-03-17 MX MX2015012879A patent/MX2015012879A/es unknown
- 2014-03-17 LT LTEP14719486.4T patent/LT2968225T/lt unknown
- 2014-03-17 CA CA3018668A patent/CA3018668C/en active Active
- 2014-03-17 CN CN201480015980.0A patent/CN105142625B/zh active Active
- 2014-03-17 EP EP18215029.2A patent/EP3492075B1/en active Active
- 2014-03-17 EP EP14719486.4A patent/EP2968225B1/en active Active
- 2014-03-17 RS RS20190594A patent/RS58750B1/sr unknown
- 2014-03-17 PL PL14719486T patent/PL2968225T3/pl unknown
- 2014-03-17 AU AU2014232881A patent/AU2014232881B2/en active Active
- 2014-03-17 KR KR1020247009397A patent/KR20240042210A/ko not_active Application Discontinuation
- 2014-03-17 KR KR1020217012549A patent/KR20210062693A/ko active Application Filing
- 2014-03-17 DK DK14719486.4T patent/DK2968225T3/da active
- 2014-03-17 JP JP2016503385A patent/JP6313420B2/ja active Active
- 2014-03-17 PT PT14719486T patent/PT2968225T/pt unknown
- 2014-03-17 KR KR1020157029781A patent/KR20150131330A/ko not_active IP Right Cessation
- 2014-03-17 CA CA2906851A patent/CA2906851C/en active Active
- 2014-03-17 WO PCT/US2014/030372 patent/WO2014145580A1/en active Application Filing
- 2014-03-17 ES ES14719486T patent/ES2727292T3/es active Active
- 2014-03-17 RU RU2015143665A patent/RU2015143665A/ru not_active Application Discontinuation
- 2014-07-15 US US14/331,947 patent/US8975268B2/en active Active
- 2014-07-15 US US14/331,983 patent/US8975281B2/en active Active
-
2015
- 2015-09-09 IL IL241346A patent/IL241346B/en active IP Right Grant
- 2015-09-09 CL CL2015002534A patent/CL2015002534A1/es unknown
-
2016
- 2016-06-03 HK HK16106356.7A patent/HK1218384A1/zh unknown
-
2017
- 2017-04-10 AU AU2017202343A patent/AU2017202343B2/en active Active
- 2017-11-24 RU RU2017141000A patent/RU2673081C1/ru active
-
2019
- 2019-03-04 HR HRP20190419TT patent/HRP20190419T1/hr unknown
- 2019-04-16 CY CY20191100416T patent/CY1121606T1/el unknown
- 2019-04-26 US US16/396,071 patent/US10881647B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190419T1 (hr) | Kombinacijske formulacije neosaksitoksina za produženu lokalnu anesteziju | |
| EP3065716C0 (en) | FORMULATIONS | |
| HRP20180684T1 (hr) | Kombinacija lijekova | |
| HK1218076A1 (zh) | 穩定的培美曲塞製劑 | |
| IL243080B (en) | Helmet for anesthesia | |
| EP2964658A4 (en) | SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS | |
| AU353438S (en) | Bed rail | |
| GB201319792D0 (en) | Formulations | |
| EP2910227A4 (en) | REMOVABLE BED | |
| HK1214951A1 (zh) | 眼用製劑 | |
| HK1224228A1 (zh) | 新型製劑 | |
| IL242493A0 (en) | Pharmaceutical formulations relieve radioactivity | |
| EP3017727A4 (en) | CUSHION FOR SHARED SLEEP | |
| SG11201507957VA (en) | Stabilized vitamin d formulations | |
| PL2821061T3 (pl) | Nowe preparaty do inhalacji | |
| KR101560096B9 (ko) | 구조물의 수평, 수직도 조절 위한 트랜지션 피스 | |
| GB2517922B (en) | Train set | |
| IL246393A0 (en) | Prodrug compounds | |
| GB2516706B (en) | Railway points | |
| GB201320093D0 (en) | Tram | |
| AU352341S (en) | Fitting for furniture | |
| AU352342S (en) | Fitting for furniture | |
| AU352352S (en) | Locomotive | |
| AU352351S (en) | Locomotive | |
| GB201318903D0 (en) | Hyrdolic cot rail |